Results for “”

Entry Author Date Location
Second US Gene Therapy, Approved for Rare Muscle Disease, to Cost $2M 05/24/19 National
Bio Roundup: Zolgensma Watch, Brain Cancer Blues, Peloton Payout & More 05/24/19 National
Nektar Forms New Company Inheris to Take Reins on Pain, CNS Drugs 05/23/19 San Francisco
Agrilyst Rebrands as Artemis, Lands $8M for Indoor Farming Software 05/22/19 New York
With $120M, AlloVir Faces Big Test of Cell Therapy to Fight Infection 05/22/19 Texas
Sebastian Thrun and Udacity Launch New Self-Driving Nanodegree 05/21/19 San Francisco
Merck Preempts Peloton Therapeutics IPO With $1B Acquisition Deal 05/21/19 New York
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms 05/20/19 New York
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More 05/17/19 National
ASCO Abstracts: Breast Cancer, Precision Treatments in the Spotlight 05/16/19 National
Endpoint Security Company CrowdStrike Files Publicly for IPO 05/14/19 San Francisco
Bio Roundup: Rare Disease Showdowns, Prices on TV, Dealmania & More 05/10/19 National
Uber Completes $8.1B Public Market Debut in Spite of Tumultuous Past 05/09/19 San Francisco
Two Days, Five Biotech IPOs, and $359M Raised for Clinical Trials 05/09/19 National
SMA, Migraine Data Lead Neuro Highlights from AAN Meeting 05/07/19 National
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea 05/06/19 New York
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More 05/03/19 National
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments 05/03/19 National
Beyond Meat’s IPO Bags $241M to Make Plant-Based Burgers Mainstream 05/02/19 National
SMA Moment: Will Gene Therapy Shift Treatment, Costs of Muscle Disease? 05/02/19 National
Retailers, Startups Work to Offer Efficient E-Commerce Delivery 05/01/19 National
Publishers Cengage, McGraw-Hill Merge to Better Target Edtech Market 05/01/19 Boston
Another $568M, and a $7B Valuation, for Automation Firm UiPath 04/30/19 San Francisco
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More 04/26/19 National
Dave, More Chips on Aisle 3: Walmart Opens AI-Enabled Store in NY 04/25/19 New York
Teva’s Approved Migraine Drug Fails Again to Blunt Rarer Headache 04/23/19 New York
SPECIAL REPORT: 2019 Blockchain Outlook — Reality Check 04/23/19 National
Can We Afford to Be Cured? A Conversation With ICER’s Steve Pearson 04/23/19 Boston
Merck Wins FDA Nod for Combo Therapy in Advanced Kidney Cancer 04/22/19 New York
Bio Roundup: Nationwide’s Rise, a Surgeon’s Quest, CRISPR USA & More 04/19/19 National
Page 1 of 82 next page »